PolyPid Ltd.
PYPD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001611842
No open-market purchases or sales by PolyPid Ltd. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $16.7M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding PolyPid Ltd. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 16 | 19 | +3 |
| Shares | 2.83M | 3.00M | +170.4K (+6.0%) |
| Value | $9.45M | $13.0M | +$3.59M (+38.0%) |
New holders (5)
Institutions that held PolyPid Ltd. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ADAR1 Capital Management, LLC | 103,950 | $451.1K | 0.03% |
| Jane Street Group, LLC | 15,199 | $66.0K | 0.00% |
| National Asset Management, Inc. | 15,130 | $65.7K | 0.00% |
| Citadel Advisors LLC | 10,723 | $46.5K | 0.00% |
| HighTower Advisors, LLC | 10,244 | $44.5K | 0.00% |
Sold out (2)
Institutions that held PolyPid Ltd. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Goldman Sachs Group Inc | 14,292 | $47.7K |
| JPMorgan Chase & Co | 435 | $1.45K |